Medicare Pays Billions For Obesity’s Consequences. Its GLP-1 Bridge Offers A Better Way
This month, the Centers for Medicare and Medicaid Services launched the Medicare GLP-1 Bridge, a demonstration program that gives eligible Medicare beneficiaries access to certain anti-obesity medicines for $50 a month.
BlogZone shows headlines and summaries from public news feeds. The full story is published by Forbes Business.
Read the full story at Forbes Business →Enjoyed this?
Get more stories like this — and write your own — in the BlogZone app.


